International Journal of Nephrology / 2018 / Article / Tab 3

Research Article

Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

Table 3

Base case results (3% discount on costs and outcomes).

TreatmentLifetime cost per patient (RM)Effect (LY)ICER (Cost per LY gained)Effect (QALY)ICER (Cost per QALY gained)

CaCO377,1394.25-3.54-
Sevelamer159,9016.37-5.27-
Incremental82,7632.1239,0501.7447,679

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.